Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Inari VISION Registry

Sponsor: Inari Medical

NCT ID: NCT06600542

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Inari Medical Commercially Available Devices (device)
How long the study runs
Study runs about 57 months (dates as stated)
About the drug or intervention
Inari Medical Commercially Available Devices — device: Commercially approved Inari Medical devices
Patient visit burden
Not specified by the sponsor

In plain English

This registry, run by Inari Medical, collects information from people who have been treated with an Inari Medical device for a pulmonary embolism (a blood clot in the lungs). The aim is to gather details about their treatment and follow-up over time.

Who can take part

  • Able and willing to give informed consent
  • Has been treated with an eligible Inari Medical device
  • Is within the enrolment window for their procedure
  • Aged 18 or over

Who may not be able to

  • Cannot be reached for registry follow-up
  • Meets local exclusion requirements
  • Is taking part, or plans to take part, in another drug or device study that could interfere with this registry
  • Is pregnant or breastfeeding at the time of enrolment

What taking part involves

  • • Not stated — ask the trial team

Time commitment: Not stated — ask the trial team

Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.

Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
1,000
Started
2025-03-07
Last checked
2026-08

Plain English Summary

What is this study?

  • • Testing a new treatment for pulmonary embolism
  • • Clinical study - 1,000 participants
  • • This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with pulmonary embolism

Where?

  • • Bristol - Southmead Hospital Bristol
  • • Glasgow - Queen Elizabeth University Hospital
  • • London - Northwick Park Hospital
  • • London - Royal Free Hospital
  • • +4 more UK sites

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Pulmonary Embolism

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Willing and able to provide agreement to take part per institution and geographical requirements
  • ✓Currently within enrollment window relative to their procedure
  • ✓Age ≥ 18 years

Who cannot take part

  • ✗Is or will be inaccessible for registry follow-up
  • ✗Meets exclusion criteria required by local requirements
  • ✗Current or planned participation in another drug or device study that, in the investigator's opinion, would...
  • ✗Is pregnant or breastfeeding at the time of enrollment
See the full criteria
Inclusion Criteria: 1. Willing and able to provide informed consent per institution and geographical requirements 2. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure. 3. Currently within enrollment window relative to their procedure 4. Age ≥ 18 years Exclusion Criteria: 1. Is or will be inaccessible for registry follow-up 2. Meets exclusion criteria required by local requirements 3. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry 4. Is pregnant or breastfeeding at the time of enrollment

Where Is This Study? (8 UK sites)

Southmead Hospital Bristol

Bristol, United Kingdom

Recruiting

Queen Elizabeth University Hospital

Glasgow, United Kingdom

Recruiting
Hospital R&D contact (matched)

Tom Dymond

research&development@qehkl.nhs.uk01553 613532

Northwick Park Hospital

London, United Kingdom

Recruiting

Royal Free Hospital

London, United Kingdom

Recruiting
Hospital R&D contact (matched)

Natasha Ajraam

rf-tr.randd@nhs.net020 375 82150

Royal London

London, United Kingdom

Recruiting
Hospital R&D contact (matched)

Natasha Ajraam

rf-tr.randd@nhs.net020 375 82150

UCLH University College London Hospital

London, United Kingdom

Recruiting
Hospital R&D contact (matched)

Rajinder Sidhu - Associate Director, Research Governance and Operations

uclh.jro-communications@nhs.net020 3447 9825

Royal Victoria Infirmary

Newcastle, United Kingdom

Recruiting
Hospital R&D contact (matched)

Colleen Bowthorpe

colleen.bowthorpe@nhs.scot01387 241815

Great Western Hospital

Swindon, United Kingdom

Recruiting
Hospital R&D contact (matched)

Dr Donna Noonan

gwh.researchmanagement@nhs.net01793 605565

How to Get in Touch

Ida Nelson

Sponsor contact

CONTACT

46 707 723010 ida.nelson@inarimedical.com
Data sourced from ClinicalTrials.gov · Last verified: 2026-08